Skip to content

Progressive Resistance Training for Fibromyalgia

Evaluation of the Effectiveness of a Progressive Resistance Training Program for Patients With Fibromyalgia: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03588208
Enrollment
60
Registered
2018-07-17
Start date
2016-02-01
Completion date
2018-03-25
Last updated
2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Fibromyalgia, Pain, Function, Quality of life

Brief summary

Patients in the experimental group underwent a progressive resistance training program, performed twice a week for 12 weeks. The charge intensity was progressively increased from 40% to 80% of 1 repetition maximum. The following muscle groups were worked: trunk flexors and extensors, elbow flexors and extensors, knee flexors and extensors, hip abductors and adductors and shoulder abductors. In addition to strength training, the experimental group also conducted a structured education program in one hour class once a week for five weeks. Patients in the control group performed the same education program.

Interventions

Progressive resistance training program were performed twice a week for 12 weeks. The charge intensity was progressively increased from 40% to 80% of 1 repetition maximum. The following muscle groups were worked: trunk flexors and extensors, elbow flexors and extensors, knee flexors and extensors, hip abductors and adductors and shoulder abductors. In addition to strength training.

OTHEREducational Program

Structured education program were performed during one hour class once a week for five weeks

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Healthy volunteers
No

Inclusion criteria

* Diagnosis of fibromyalgia according to the criteria of the American College of Rheumatology; * Feminine gender; * Age between 18 and 65 years; * Pain between 3 and 8 cm in the Numerical Pain Scale (END); * Have not changed treatment for fibromyalgia in the past three months; * Agree to participate in the study and sign the informed consent form.

Exclusion criteria

* Cognitive deficit that does not allow the understanding of the evaluation instruments; * Other diseases that make it impossible to perform the exercises; * Physical activity started or changed in the last three months; * Physical therapy in the last six months; * In litigation.

Design outcomes

Primary

MeasureTime frameDescription
Change in painBaseline and after 6 and 12 weeksMeasured by numerical pain scale

Secondary

MeasureTime frameDescription
Change in Health related quality of lifeBaseline and after 6 and 12 weeksMeasured by Fibromyalgia Impact Questionnaire
Change in Generic quality of lifeBaseline and after 6 and 12 weeksMeasured by the Medical Outcome Survey Short Form 36
Change in Functional capacityBaseline and after 6 and 12 weeksMeasured by the 6-minute Walk Test
Change in strengthBaseline and after 6 and 12 weeksMeasured by the 1 repetition maximum

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026